Menezes, Mitchell E <br/><br/>
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.  [electronic resource] 

 -  Oncotarget  Dec 2016 
 - 80175-80189 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.13373  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actin Cytoskeleton--enzymology<br/>Animals<br/>Breast Neoplasms--enzymology<br/>Cell Line, Tumor<br/>Cell Movement<br/>Cell Shape<br/>Epithelial-Mesenchymal Transition<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Lung Neoplasms--enzymology<br/>Mice, Nude<br/>Neoplasm Invasiveness<br/>Phenotype<br/>Protein Interaction Domains and Motifs<br/>RNA Interference<br/>Signal Transduction<br/>Syntenins--genetics<br/>Time Factors<br/>Transfection<br/>Transforming Growth Factor beta1--genetics<br/>cdc42 GTP-Binding Protein--genetics<br/>rhoA GTP-Binding Protein--genetics